Clinical Trials Logo

Central Nervous System Injury clinical trials

View clinical trials related to Central Nervous System Injury.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03291366 Active, not recruiting - Clinical trials for Central Nervous System Injury

Mesenchymal Stem Cells in Central Nervous System injury2017

Start date: January 2017
Phase: Phase 1/Phase 2
Study type: Interventional

Central nervous system (CNS) injury leads to morbidity in patients, which has few good rehabilitation measures. Mesenchymal stem cells seem to have regenerative and tissue-repairing capabilities. The investigators design this study to infuse mesenchymal stem cells (MSCs) intrathecally to CNS injury patients, and observe the safety and efficacy by recording the change of nervous system scores, trying to prove the effect of MSC in rehabilitate CNS injury.